Status:
COMPLETED
COVID-19 Associated Coagulopathy in Egypt
Lead Sponsor:
Assiut University
Conditions:
Coagulopathy
Eligibility:
All Genders
Brief Summary
Coagulopathy is one of the most significant prognostic factors in patients with COVID-19 and is associated with increased mortality and admission to critical care. Most commonly observed coagulopathy ...
Detailed Description
studying the detailed coagulation screen and second line coagulation parameters including both thrombophilia screen and other acute phase coagulation factors.
Eligibility Criteria
Inclusion
- patients with COVID 19 positive by RT- PCR
Exclusion
- no exclusions
Key Trial Info
Start Date :
August 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04507230
Start Date
August 7 2020
End Date
October 31 2020
Last Update
March 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Egypt, 71515